US38246G1085
© BusinessWire
16.12.2025
GDRX
LISTED
NASDAQ
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2026 at 1:30 p.m. Pacific Time (4:30 p.m. E...
Themefolio
Profiler
Peergroup
© BusinessWire
17.11.2025
GDRX
LISTED
NASDAQ
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for Weight Loss, a telemedicine subscription that connects consumers to licensed healthcare providers for affordable weight management treatm...
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2025
GDRX
LISTED
NASDAQ
GoodRx Reports Third Quarter 2025 Results
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the third quarter of 2025.
Third Quarter 2025 Highlights
Revenue of $196.0 million
Net income of $1.1 million; Net income margin of 0.6%
Adjusted Net Income1 of...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
15.10.2025
GDRX
LISTED
NASDAQ
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription for hair loss treatment. Built for simplicity and transparency, GoodRx for Hair Loss helps men access affordable treatments that are clinically proven to slow hair loss and support regrowth.
This press release features...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
08.10.2025
GDRX
LISTED
NASDAQ
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after U.S. markets close on Tuesday, November 4, 2025. GoodRx management will also hold a conference call and webcast the following morning, Wednesday, N...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
GDRX
LISTED
NASDAQ
GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of Repatha® (evolocumab), a cholesterol-lowering therapy, at a significantly reduced cash price. Starting today, patients can use GoodRx to access Repatha for $239 at more than 70,000 pharmacies nationwide, a savings of nearly 60% off t...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2025
GDRX
LISTED
NASDAQ
GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of its brand medication savings solution, RxSmartSaver powered by GoodRx, at Kroger pharmacies nationwide. RxSmartSaver brings medication affordability directly to the pharmacy counter, improving the patient experience while delivering...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
GDRX
LISTED
NASDAQ
GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., is riding into new creative territory with the launch of The Savings Wrangler, a groundbreaking brand campaign that aims to bring the company’s mission to life in an unforgettable way. Designed to deepen cultural relevance and brand resonance, the campaign introduces a...
Themefolio
Profiler
Peergroup
© BusinessWire
28.07.2025
GDRX
LISTED
NASDAQ
GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and President of Pharma Solutions, effective July 28, 2025. In this role, Laura will lead the company’s Pharma Manufacturer Solutions offering and oversee strategic initiatives aimed at growing...
Themefolio
Profiler
Peergroup
© BusinessWire
19.07.2025
GDRX
LISTED
NASDAQ
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX
News Preview
The law firm of Kahn Swick & Foti, LLC (“KSF”) has commenced an investigation into GoodRx Holdings, Inc. (NasdaqGS: GDRX) (“GoodRx”). KSF is investigating whether GoodRx’s officers and/or directors breached their fiduciary duties or otherwise violated state or federal laws.
If you hold shares of GoodRx Holdings, Inc. (Nasdaq: GDRX), we urge...
Themefolio
Profiler
Peergroup
© BusinessWire
09.07.2025
GDRX
LISTED
NASDAQ
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its second quarter 2025 financial results after U.S. markets close on Wednesday, August 6, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, A...
Themefolio
Profiler
Peergroup
© BusinessWire
10.06.2025
GDRX
LISTED
NASDAQ
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription service for erectile dysfunction (ED). Designed to meet consumers where they are and remove common barriers such as high costs, long wait times, and inconvenience, this all-in-one solution offers a fast, discreet, and af...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
09.06.2025
GDRX
LISTED
NASDAQ
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of GoodRx Community Link. Designed to address the industry challenges that independent community pharmacies face around complex reimbursement models and competitive pressures, Community Link leverages a cost-plus pricing model based on NADAC...
Themefolio
Profiler
Peergroup
© BusinessWire
05.06.2025
GDRX
LISTED
NASDAQ
GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced it is open-sourcing Lifecycle, a homegrown development tool designed to improve team velocity, streamline review workflows, and reduce infrastructure overhead.
Lifecycle is now available to the public under the Apache 2.0 license, inviting developers...
Themefolio
Profiler
Peergroup
© BusinessWire
22.05.2025
GDRX
LISTED
NASDAQ
GoodRx to Launch Direct Contracting for Independent Community Pharmacies
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that it will launch a new offering for independent community pharmacies - GoodRx Community Link - in June 2025. GoodRx Community Link will enable locally owned and operated pharmacies to directly contract with GoodRx on pricing and manage participation...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
GDRX
LISTED
NASDAQ
GoodRx Reports First Quarter 2025 Results
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025.
First Quarter 2025 Highlights
Revenue of $203.0 million
Net income of $11.1 million; Net income margin of 5.4%
Adjusted Net Income1 o...
Themefolio
Profiler
Peergroup
© BusinessWire
09.04.2025
GDRX
LISTED
NASDAQ
GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close on Wednesday, May 7, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 8...
Themefolio
Profiler
Peergroup
© BusinessWire
03.04.2025
GDRX
LISTED
NASDAQ
GoodRx Introduces New E-commerce Experience for Retail Pharmacies
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced a new e-commerce experience for retail pharmacies that improves how consumers get their medications via the GoodRx platform. The company is launching the experience with Midwest-based retailer Hy-Vee.
This press release features multimedia. View the ful...
Themefolio
Profiler
Peergroup
© BusinessWire
17.03.2025
GDRX
LISTED
NASDAQ
GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement, effective immediately.
Aaron will be responsible for the management and financial performance of GoodR...
Themefolio
Profiler
Peergroup
© BusinessWire
10.03.2025
GDRX
LISTED
NASDAQ
GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that in 2024, women spent $8.8 billion – or 30% – more than men on out-of-pocket prescription costs...
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
GDRX
LISTED
NASDAQ
GoodRx Reports Fourth Quarter and Full Year 2024 Results
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the fourth quarter and full year of 2024.
Fourth Quarter 2024 Highlights
Revenue1 of $198.6 million
Net income of $6.7 million; Net income margin of 3.4%
Adju...
Themefolio
Profiler
Peergroup
© BusinessWire
18.02.2025
GDRX
LISTED
NASDAQ
GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
News Preview
GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., today announced its drug savings platform residing with Amazon Web Services (AWS) has earned certified status for 2025 by HITRUST for information security. This milestone underscores GoodRx’s dedication to safeguarding data and maintaining specific standards of cybersecuri...
Themefolio
Profiler
Peergroup
© BusinessWire
05.02.2025
GDRX
LISTED
NASDAQ
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
News Preview
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced that Christopher A. McGinnis has been appointed as Chief Financial Officer, effective February 4, 2025. Chris brings 30 years of extensive financial experience across the healthcare industry to his new role.
Chris will join GoodRx following his role as...
Themefolio
Profiler
Peergroup
© BusinessWire
30.01.2025
GDRX
LISTED
NASDAQ
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial results before U.S. markets open on Thursday, February 27, 2025. GoodRx management will also hold a conference call and webcast that morning at 5:00...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2025
GDRX
LISTED
NASDAQ
Scott Wagner Joins GoodRx Board of Directors
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that Scott Wagner has joined its Board of Directors, effective January 21, 2025. Mr. Wagner, who recently led GoodRx as its Interim Chief Executive Officer from April 2023 to January 2025, has...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2025
GDRX
LISTED
NASDAQ
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications
News Preview
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more affordable and convenient way for Americans to access pet medications. Through GoodRx for Pets, pet owners can find savings and have pet medications delivered right to their door. GoodRx for Pets provi...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
GDRX
LISTED
NASDAQ
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m....
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2024
GDRX
LISTED
NASDAQ
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
News Preview
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today revealed startling healthcare disparities in its new report, “Endocrinologist Deserts: A Critical Healthcare Gap for Millions in the U.S.” With nearly 70% of U.S. counties lacking an endocrinologist, the report paints a stark picture of the barriers millions of Ame...
Themefolio
Profiler
Peergroup
© BusinessWire
16.12.2024
GDRX
LISTED
NASDAQ
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
News Preview
GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President and Chief Executive Officer, effective January 1, 2025. Wendy brings more than 30 years of leadership experience across the pharmacy and medical benefit industry to her new role.
This press...
Themefolio
Profiler
Peergroup
© BusinessWire
05.12.2024
GDRX
LISTED
NASDAQ
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
News Preview
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look at fill trends and spending patterns for weight loss medications across the U.S. The company found that limited insurance coverage and high out-of-pocket costs aren’t slowing down interest...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
GDRX
LISTED
NASDAQ
GoodRx Reports Third Quarter 2024 Results
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024.
Third Quarter 2024 Highlights
Revenue1 and Adjusted Revenue1 of $195.3 million
Net income of $4.0 million; Net income margin of 2.0%
Ad...
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2024
GDRX
LISTED
NASDAQ
GoodRx to Participate in Upcoming Investor Conferences
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences:
UBS 2024 Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 12, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2024
GDRX
LISTED
NASDAQ
GoodRx Unveils New E-commerce Platform, Launches with Opill®
News Preview
Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the rollout of its new e-commerce solution, with Opill® as its launch partner. This new seamless direct-to-consumer shopping experience allows consumers to order eligible health products and medications on the GoodRx platform and have them shipped direct...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2024
GDRX
LISTED
NASDAQ
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
News Preview
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release capsules CIV) is available for a low cash price in more than 70,000 retail pharmacy locations nationwide exclusively via GoodRx. This initiative not only propels GoodRx’s momentum in weight loss so...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2024
GDRX
LISTED
NASDAQ
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
News Preview
Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormone therapies by Pfizer. Through the reach and scale of the GoodRx platform, these programs are broadening access and affordability of crucial medications for women.
This press release feat...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2024
GDRX
LISTED
NASDAQ
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
News Preview
GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be able to use Affirm to pay over time for select medications at participating retail pharmacies. This adds a convenient way for consumers to pay for their medications directly on the GoodRx platform.
GoodRx is launching this program...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2024
GDRX
LISTED
NASDAQ
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, November 7, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Ti...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2024
GDRX
LISTED
NASDAQ
GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
News Preview
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS Pharmaceuticals, Inc. (“ARS Pharmaceuticals”) to offer the lowest discounted cash price for neffy® in retail pharmacy locations. Available for purchase in-store this week, consumers who have been prescribed neffy can now access a pa...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2024
GDRX
LISTED
NASDAQ
GoodRx to Participate in Upcoming Investor Conferences
News Preview
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences:
Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Thursday, Septembe...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
